In Vitro vs In Vivo Data in ANDA Filings
In Vitro vs In Vivo Data in ANDA Filings When In Vitro Data Can Replace In Vivo Studies in ANDA Submissions Understanding In Vitro and In Vivo Requirements Generic drug applicants must demonstrate bioequivalence to a Reference Listed Drug (RLD) as part of an Abbreviated New Drug Application (ANDA). This bioequivalence can be shown through…